Indications and uses
For the management of acne.
For the management of acne.
• Cleanse skin thoroughly before applying this product. • Cover the entire affected area with a thin layer one to three times daily. • Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by doctor. • If bothersome dryness or peeling occurs, reduce application to once a day or every other day.
• may stain some fabrics
Salicylic Acid 0.5%
Acne Medication
For external use only
• skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs only use one topical acne medication at a time. • Avoid contact with eyes. If contact occurs, flush thoroughly with water.
If swallowed, get medical help or contact a Poison Control Center right away.
• Cleanse skin thoroughly before applying this product. • Cover the entire affected area with a thin layer one to three times daily. • Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by doctor. • If bothersome dryness or peeling occurs, reduce application to once a day or every other day.
• may stain some fabrics
Water, Dicaprylyl Ether, Glycerin, Cetearyl Alcohol, Dimethicone, Neopentyl Glycol Diisostearate, Neopentyl Glycol Diethylhexanoate, Aluminum Starch Octenylsuccinate, Methyl Gluceth-20, Dicetyl Phosphate, Ceteth-10 Phosphate, Mentyl Lacatate, Steareth-21, Steareth-2, Fragrance, Xanthan Gum, Disodium EDTA, Sodium Hydroxide, Magnesium Aluminum Silicate, BHT.
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 11673-931 | 11673-931-53 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 247674df-5c13-a462-e063-6394a90ac7b9 | 933feba6-df4b-ebb9-e053-2995a90af459 | 2024-10-14 | Warnings | 933feba6-df4b-ebb9-e053-2995a90af459 |
Adverse event summaries are temporarily unavailable. Other product information remains available.